Outcomes Research, Animal Health Center for Observational and Real-World Evidence,
Merck & Co. Inc., Kenilworth, NJ 07033
Tanzania
Research Article
Results from a U.S. Dog Owner Survey on the Treatment Satisfaction and Preference for Fluralaner against Flea and Tick Infestations
Author(s): Robert P Lavan, Robert Armstrong, Dorothy Normile, Dongmu Zhang and Kaan TunceliRobert P Lavan, Robert Armstrong, Dorothy Normile, Dongmu Zhang and Kaan Tunceli
Background: Fluralaner is a potent acaricide and insecticide effective against flea and tick (F/T) infestations on dogs and cats. Fluralaner for dogs can be administered orally as a flavored chew with up to a 12-week redosing interval, about three-fold less frequently than monthly F/T medications. This study surveyed dog owners who currently administer fluralaner to their dogs to determine their level of satisfaction with the product and its perceived benefits compared to monthly medications, including the potential for on-time administration compliance.
Methods: In the period April to June 2016, dog-owner clients from 25 veterinary practices in 16 U.S. states completed a 10-item survey questionnaire (n=559) that asked respondents about their experience with fluralaner and monthly medications. In multivariate analyses, predictors of treatmen.. Read More»
DOI:
10.4172/2157-7579.1000439
Veterinary Science & Technology received 4472 citations as per Google Scholar report